REDOXOPHORE
DEAD

Serial Number

76354629

Owner

Galileo Laboratories, Inc.

Attorney

Lynn M. Humphreys

Filing Date

Jan 3, 2002

Add to watchlist:

No watchlists yet
View on USPTO

REDOXOPHORE Trademark

Serial Number: 76354629

REDOXOPHORE is a trademark filed by Galileo Laboratories, Inc. on January 3, 2002. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Galileo Laboratories, Inc. (13 trademarks)

5301 Patrick Henry Drive
Santa Clara, CA 95054

Entity Type: 03

Trademark Details

Filing Date

January 3, 2002

Registration Date

Not Registered

Published for Opposition

January 7, 2003

Goods & Services

Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles, excessive cellulite, excessive pore size, intrinsic skin aging, photo aging, photo damage, harmful UV damage, keratinization abnormalities, alopecia, dyspigmentation inflammation due to wounds, scarring or stretch marks, loss of elasticity, skin atrophy, pigmentation control, psoriasis, inhibition of hair growth, inhibition of hair loss, stimulation of hair growth, gingivitis, central nervous system ischemia resulting from cardiac arrest, hypoxemia, transient ischemic attack, stroke or severe hypotension; cerebral ischemia including stroke, ischemic heart disease myocardial ischemia), spinal cord ischemia and paraplegia, retinal ischemia including age-related macular degeneration (ARMD), hepatic ischemia, renal ischemia, dermal ischemia, penile ischemia, pulmonary ischemia, gastric ischemia intestinal ischemia, splenic ischemia, pancreatic ischemia, skeletal muscle ischemia, ischemia associated with diabetic ulcers, gangrenous conditions, post-trauma syndrome, benign prostatic hyperplasia of hypertrophy (BPH), post prostate cancer surgery, cardiac arrest resuscitation, peripheral nerve damage or neuropathise, and dietary and nutritional supplements

Non-medicated skin care preparations, namely creams, lotions, cleansers, moisturizers, astringents, emollients, exfoliators, sunscreens, mousses, toners, masks, powders, foundations, cosmetics, gels, pastes, roll-ons, patches, pads, tissues, wipes, antiperspirants, deodorants, nail polish, hair conditioners, shampoos, scalp treatments

chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplements

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 9, 2005 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 9, 2005 ABN6
CASE FILE IN TICRS
Aug 10, 2004 CFIT
PAPER RECEIVED
Jul 12, 2004 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2004 TCCA
SOU EXTENSION 2 GRANTED
Jun 11, 2004 EX2G
SOU EXTENSION 2 FILED
Mar 11, 2004 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 11, 2004 EEXT
SOU EXTENSION 1 GRANTED
Dec 19, 2003 EX1G
SOU EXTENSION 1 FILED
Sep 19, 2003 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 19, 2003 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 1, 2003 NOAM
PUBLISHED FOR OPPOSITION
Jan 7, 2003 PUBO
NOTICE OF PUBLICATION
Dec 18, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2002 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2002 TROA
NON-FINAL ACTION MAILED
Apr 23, 2002 CNRT